Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Med Oncol ; 36(9): 78, 2019 Aug 02.
Artículo en Inglés | MEDLINE | ID: mdl-31375946

RESUMEN

Cigarette smoking is directly associated with lung cancer. Non-small cell lung carcinoma (NSCLC) represents approximately 80% from all types of lung cancer. This latter is hard to diagnose and to treat due to the lack of symptoms in early stages of the disease. The aim of this study was to evaluate ADA activity and the expression of P2X7, A1, and A2A receptors and in lymphocytes. In addition, the profile of pro-inflammatory and anti-inflammatory cytokines serum levels of patients with lung cancer in advanced stage was evaluated. Patients (n = 13) previously treated for lung cancer at stage IV (UICC) with chemotherapy had their blood collected. Cancer patients showed a decrease in ADA activity and an increase in A1 receptor expression in lymphocytes when compared to the control group. Moreover, patients exhibited an increase in IL-6 and TNF-α, while IL-17 and INF-ϒ serum levels were lower in patients with lung cancer. The decreased ADA activity and the increase in A1 receptor expression may contribute to adenosine pro-tumor effects by increasing IL-6 and TNF-α and decreasing IL-17 and INF-γ serum levels. Our data show an indirect evidence that purinergic signaling may have a role in promoting a profile of cytokines levels that favors tumor progression.


Asunto(s)
Adenosina Desaminasa/metabolismo , Carcinoma de Pulmón de Células no Pequeñas/enzimología , Carcinoma de Pulmón de Células no Pequeñas/patología , Neoplasias Pulmonares/enzimología , Neoplasias Pulmonares/patología , Linfocitos/enzimología , Anciano , Anciano de 80 o más Años , Carcinoma de Pulmón de Células no Pequeñas/sangre , Carcinoma de Pulmón de Células no Pequeñas/metabolismo , Citocinas/sangre , Femenino , Humanos , Neoplasias Pulmonares/sangre , Neoplasias Pulmonares/metabolismo , Linfocitos/metabolismo , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Receptores Purinérgicos/metabolismo , Transducción de Señal
2.
Mol Cell Biochem ; 403(1-2): 169-77, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25720338

RESUMEN

Hypoxic-ischemic (HI) injury perinatal brain is a major contributor to morbidity and mortality to infants and children. Adenosine may play a role in the pathophysiology of HI, since it modulates the inflammatory process and the release of several neurotransmitters. Thus, the aim of this study was to identify the isoforms of adenosine deaminase (ADA) responsible for the enzymatic activity as well as the adenosine kinase (ADK) and A1 adenosine receptor (A1R) expression in the cerebral cortex eight days after HI. Myeloperoxidase (MPO) and N-acetyl-glucosaminidase (NAG) were assessed as inflammation markers. ADA activity was analyzed, in the presence or absence of a specific ADA1 inhibitor, erythro-9-(2-hydroxy-3-nonyl) adenine. The ADA1 activity (92.6%) was significantly higher than ADA2 (7.4%) activity in the cerebral cortex eight days after HI. A1Rs and ADK protein expression showed decreased 8 days after insult. Interestingly, the ADA1, MPO, and NAG activities were correlated positively. In view of this, we conclude that the inhibitor of ADA1, in in vitro conditions, was effective in decreasing the ADA activity, and that mainly ADA1 isoform is responsible for the increase in the ADA activity 8 days after HI insult. Therefore, HI neonatal was able to alter the ADK and A1R expression. Thus, due to the importance of adenosine signaling in the regulation of inflammatory and immune process and the crucial role of ADA in the postischemic homeostase of adenosine as well as during inflammatory process, we suggest that ADA1 inhibitors may play an important role in the regulation of events that follow the HI insult, favoring the increase in the adenosine in the sites of tissue injury. Together, these results highlight a role of the purinergic signaling cascade in the pathophysiology of HI neonatal.


Asunto(s)
Adenosina Desaminasa/metabolismo , Encéfalo/patología , Hipoxia-Isquemia Encefálica/enzimología , Hipoxia-Isquemia Encefálica/patología , Inflamación/patología , Purinas/metabolismo , Acetilglucosaminidasa/metabolismo , Adenina/análogos & derivados , Adenina/farmacología , Adenosina Quinasa/metabolismo , Animales , Animales Recién Nacidos , Western Blotting , Corteza Cerebral/enzimología , Corteza Cerebral/patología , Isoenzimas/metabolismo , Masculino , Peroxidasa/metabolismo , Ratas Wistar , Receptor de Adenosina A1/metabolismo
3.
J Nat Med ; 69(1): 46-54, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25149058

RESUMEN

This study aimed to determine the effect of lyophilized aqueous extracts of Scutia buxifolia on NTPDase and 5'-nucleotidase activity on platelets and lymphocytes as well as the profile of the platelet aggregation. In vitro tests were used to investigate the effect of the aqueous crude extract obtained from S. buxifolia leaves (SbL) and stem bark (SbS) on enzymatic activities and platelet aggregation. The platelets and lymphocytes were exposed to lyophilized aqueous extracts of S. buxifolia at concentrations of 1-200 µg/mL in the presence of ATP, ADP, AMP as substrates, during the enzymatic assay, as well as the platelet aggregation. The results showed that SbS and SbL potently inhibited NTPDase and 5'-nucleotidase in platelets and lymphocytes. ADP-induced aggregation was inhibited by the SbS (50, 100, and 200 µg/mL) and SbL (200 µg/mL). In addition, these results suggest that S. buxifolia have compounds, such as gallic acid, chlorogenic acid, caffeic acid, quercetin, rutin, and kaempferol, which cause a decrease the NTPDase and 5'-nucleotidase activity, resulting in alterations in adenine nucleotide levels and protection against ADP-induced platelet aggregation.


Asunto(s)
5'-Nucleotidasa/metabolismo , Apirasa/metabolismo , Inhibidores de Agregación Plaquetaria/farmacología , Rhamnaceae/química , Animales , Plaquetas/efectos de los fármacos , Plaquetas/enzimología , Linfocitos/efectos de los fármacos , Linfocitos/enzimología , Extractos Vegetales/química , Extractos Vegetales/farmacología , Extractos Vegetales/toxicidad , Hojas de la Planta/química , Tallos de la Planta/química , Agregación Plaquetaria/efectos de los fármacos , Inhibidores de Agregación Plaquetaria/química , Quercetina/farmacología , Ratas Wistar , Rutina/farmacología
4.
Mol Cell Biochem ; 396(1-2): 201-11, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25064450

RESUMEN

The ex vivo and in vitro effects of quercetin on NTPDase, adenosine deaminase (ADA), and acetycholinesterase (AChE) activities in lymphocytes, as well as the effects of quercetin on butyrylcholinesterase (BChE) activity in serum and myeloperoxidase (MPO) activity in plasma were determined in rats. For the ex vivo experiment, animals were orally exposed to Cadmium (Cd) for 45 days. Animals were divided into eight groups: saline/ethanol, saline/Querc 5 mg/kg, saline/Querc 25 mg/kg, saline/Querc 50 mg/kg, Cd/ethanol, Cd/Querc 5 mg/kg, Cd/Querc 25 mg/kg, and Cd/Querc 50 mg/kg. The ex vivo data showed an increase in the ATP and ADP hydrolysis and ADA activity in Cd-exposed rats when compared to the control group. The treatment with quercetin 25 and 50 mg/kg prevented this increase in the ATP and ADP hydrolysis, while the treatment with quercetin 5, 25, and 50 mg/kg prevented the increase in the ADA activity. AChE, BChE, and MPO activities ex vivo presented an increase in the Cd-exposed group when compared to the control group, and the treatment with quercetin 5, 25, and 50 mg/kg prevented this increase caused by Cd exposure. The in vitro experiment showed that quercetin 5, 10, 25, or 50 µM decreased the ADA activity proportionally to the increase of the concentrations of quercetin when compared to the control group. Thus, we can suggest that the quercetin is able to modulate NTPDase, ADA, AChE, and MPO activities and contribute to maintain the levels of ATP, adenosine, and acetylcholine normal, respectively, exhibiting potent pro-inflammatory and anti-inflammatory actions.


Asunto(s)
Cadmio/toxicidad , Colinesterasas/metabolismo , Linfocitos/efectos de los fármacos , Peroxidasa/metabolismo , Quercetina/farmacología , Acetilcolinesterasa/metabolismo , Adenosina Desaminasa/metabolismo , Animales , Butirilcolinesterasa/sangre , Relación Dosis-Respuesta a Droga , Hidrólisis , Linfocitos/metabolismo , Masculino , Sustancias Protectoras/farmacología , Pirofosfatasas/metabolismo , Ratas Wistar , Pruebas de Toxicidad/métodos
5.
Mol Cell Biochem ; 381(1-2): 1-8, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23797318

RESUMEN

This study investigated the effect of quercetin on nucleoside triphosphate diphosphohydrolase (NTP-Dase), 50-nucleotidase, adenosine deaminase (ADA), and acetylcholinesterase (AChE) activities in synaptosomes from cerebral cortex of adult rats exposed to cadmium (Cd). Rats were exposed to Cd (2.5 mg/Kg) and quercetin (5, 25 or 50 mg/Kg) by gavage for 45 days. Rats were randomly divided into eight groups (n = 8-10): saline/ethanol, saline/Querc 5 mg/kg, saline/Querc 25 mg/kg, saline/Querc 50 mg/kg, Cd/ethanol, Cd/Querc 5 mg/kg, Cd/Querc 25 mg/kg, and Cd/Querc 50 mg/kg. Results demonstrated that AChE activity increased in the Cd/ethanol group when compared to saline/ethanol group. Treatment with quercetin prevented the increase in AChE activity when compared to Cd/ethanol group. Quercetin treatment prevented the cadmium-induced increase in NTPDase, 5-nucleotidase, and ADA activities in Cd/ethanol group when compared to saline/ethanol group. Our data showed that quercetin have a protector effect against Cd intoxication. This way, is a promising candidate among the flavonoids to be investigated as a therapeutic agent to attenuate neurological disorders associated with Cd intoxication.


Asunto(s)
5'-Nucleotidasa/metabolismo , Acetilcolinesterasa/metabolismo , Cadmio/toxicidad , Corteza Cerebral/enzimología , Fármacos Neuroprotectores/farmacología , Quercetina/farmacología , Sinaptosomas/enzimología , Adenosina Desaminasa/metabolismo , Animales , Antígenos CD/metabolismo , Apirasa/metabolismo , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/patología , Hidrólisis , Masculino , Nucleótidos/metabolismo , Ratas , Ratas Wistar , Sinaptosomas/efectos de los fármacos , Sinaptosomas/patología
6.
Mol Cell Biochem ; 378(1-2): 247-55, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23516038

RESUMEN

Perinatal hypoxic-ischemic (HI) brain injury is a common problem with severe neurologic sequelae. The definitive brain injury is a consequence of pathophysiological mechanisms that begin at the moment of HI insult and may extend for days or weeks. In this context, the inflammatory response and the formation of reactive oxygen species seem to play a key role during evolution of brain damage after injury. Thus, the aim of this study was to describe the chronological sequence of acetylcholinesterase (AChE) activity and the lipid peroxidation changes in the cerebral cortex using the classic model of neonatal HI. Furthermore, the erythrocyte AChE and adenosine deaminase (ADA) activities as well as the serum levels of proinflammatory cytokines were assessed. We observed that neonatal HI caused an increase of lipid peroxidation immediately after HI insult, which remained for several days afterward. There was a time-related change in the AChE activity in the cerebral cortex and the same was observed in erythrocyte AChE and ADA activities. In addition, immediately after HI, ADA activity showed a strong positive correlation with all proinflammatory cytokines assessed. Together, these findings may help the understanding of some mechanism related to the pathophysiology of neonatal HI, therefore highlighting the putative therapeutic targets to minimize brain injury and enhance recovery.


Asunto(s)
Acetilcolinesterasa/metabolismo , Adenosina Desaminasa/metabolismo , Isquemia Encefálica/enzimología , Corteza Cerebral/enzimología , Citocinas/sangre , Eritrocitos/enzimología , Animales , Animales Recién Nacidos , Isquemia Encefálica/sangre , Hipoxia de la Célula , Corteza Cerebral/irrigación sanguínea , Mediadores de Inflamación/metabolismo , Peroxidación de Lípido , Masculino , Ratas , Ratas Wistar
7.
Food Chem Toxicol ; 56: 459-66, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23454297

RESUMEN

This study evaluated the effects of caffeic acid on ectonucleotidase activities such as NTPDase (nucleoside triphosphate diphosphohydrolase), Ecto-NPP (nucleotide pyrophosphatase/phosphodiesterase), 5'-nucleotidase and adenosine deaminase (ADA) in platelets and lymphocytes of rats, as well as in the profile of platelet aggregation. Animals were divided into five groups: I (control); II (oil); III (caffeic acid 10 mg/kg); IV (caffeic acid 50 mg/kg); and V (caffeic acid 100 mg/kg). Animals were treated with caffeic acid diluted in oil for 30 days. In platelets, caffeic acid decreased the ATP hydrolysis and increased ADP hydrolysis in groups III, IV and V when compared to control (P<0.05). The 5'-nucleotidase activity was decreased, while E-NPP and ADA activities were increased in platelets of rats of groups III, IV and V (P<0.05). Caffeic acid reduced significantly the platelet aggregation in the animals of groups III, IV and V in relation to group I (P<0.05). In lymphocytes, the NTPDase and ADA activities were increased in all groups treated with caffeic acid when compared to control (P<0.05). These findings demonstrated that the enzymes were altered in tissues by caffeic acid and this compound decreased the platelet aggregation suggesting that caffeic acid should be considered a potentially therapeutic agent in disorders related to the purinergic system.


Asunto(s)
Nucleótidos de Adenina/metabolismo , Plaquetas/efectos de los fármacos , Ácidos Cafeicos/farmacología , Linfocitos/efectos de los fármacos , Adenosina Desaminasa/metabolismo , Adenosina Trifosfatasas/metabolismo , Animales , Plaquetas/enzimología , Relación Dosis-Respuesta a Droga , Hidrólisis , Linfocitos/enzimología , Masculino , Hidrolasas Diéster Fosfóricas/metabolismo , Agregación Plaquetaria/efectos de los fármacos , Pirofosfatasas/metabolismo , Ratas , Ratas Wistar
8.
Neurochem Res ; 38(4): 886-94, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23397287

RESUMEN

It is well known that the levels of adenosine in the brain increase dramatically during cerebral hypoxic-ischemic (HI) insults. Its levels are tightly regulated by physiological and pathophysiological changes that occur during the injury acute phase. The aim of the present study was to examine the effects of the neonatal HI event on cytosolic and ecto-enzymes of purinergic system--NTPDase, 5'-nucleotidase (5'-NT) and adenosine deaminase (ADA)--in cerebral cortex of rats immediately post insult. Furthermore, the Na(+)/K(+)-ATPase activity, adenosine kinase (ADK) expression and thiobarbituric acid reactive species (TBARS) levels were assessed. Immediately after the HI event the cytosolic NTPDase and 5'-NT activities were increased in the cerebral cortex. In synaptosomes there was an increase in the ecto-ADA activity while the Na(+)/K(+) ATPase activity presented a decrease. The difference between ATP, ADP, AMP and adenosine degradation in synaptosomal and cytosolic fractions could indicate that NTPDase, 5'-NT and ADA were differently affected after insult. Interestingly, no alterations in the ADK expression were observed. Furthermore, the Na(+)/K(+)-ATPase activity was correlated negatively with the cytosolic NTPDase activity and TBARS content. The increased hydrolysis of nucleotides ATP, ADP and AMP in the cytosol could contribute to increased adenosine levels, which could be related to a possible innate neuroprotective mechanism aiming at potentiating the ambient levels of adenosine. Together, these results may help the understanding of the mechanism by which adenosine is produced following neonatal HI injury, therefore highlighting putative therapeutical targets to minimize ischemic injury and enhance recovery.


Asunto(s)
Adenosina Quinasa/metabolismo , Adenosina/metabolismo , Corteza Cerebral/metabolismo , Hipoxia-Isquemia Encefálica/fisiopatología , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , 5'-Nucleotidasa/metabolismo , Adenosina Desaminasa/metabolismo , Animales , Animales Recién Nacidos , Masculino , Nucleósido-Trifosfatasa/metabolismo , Pirofosfatasas/metabolismo , Ratas , Ratas Wistar
9.
Mol Cell Biochem ; 374(1-2): 137-48, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23180243

RESUMEN

We aimed to examine the nucleoside triphosphate diphosphohydrolases (NTPDase) in lymphocytes; adenosine deaminase (ADA) and butyrylcholinesterase (BChE) in serum; and acetylcholinesterase (AChE), superoxide dismutase (SOD), and catalase (CAT) activity in whole blood; since these enzymes are involved in inflammation responses as well as in oxidative stress conditions. We also checked the levels of total thiols (T-SH), non-protein thiols (NPSH), and thiobarbituric acid reactive substances (TBARS) in serum of patients with lung cancer. We collected blood samples from patients (n = 31) previously treated for lung cancer with chemotherapy. Patients were classified as stage IIIb and IV according to the Union for International Cancer Control (UICC). The results showed a significant increase in the hydrolysis of ATP, ADP, and adenosine in patients when compared with the control group. The activity of AChE, SOD, and CAT as well as the T-SH and NPSH levels were higher in patients group and TBARS levels were lower in patients compared with the control group. These findings demonstrated that the enzymes activity involved in the control of inflammatory and immune processes as well as the oxidative stress parameters are altered in patients with lung cancer.


Asunto(s)
Biomarcadores de Tumor/sangre , Colinesterasas/sangre , Inflamación/enzimología , Neoplasias Pulmonares/metabolismo , Estrés Oxidativo , Acetilcolinesterasa/sangre , Adenosina Desaminasa/sangre , Anciano , Antineoplásicos/uso terapéutico , Butirilcolinesterasa/sangre , Catalasa/sangre , Colinesterasas/metabolismo , Cisplatino/uso terapéutico , Desoxicitidina/análogos & derivados , Desoxicitidina/uso terapéutico , Femenino , Humanos , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/enzimología , Linfocitos/enzimología , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Nucleósido-Trifosfatasa/metabolismo , Fumar/sangre , Compuestos de Sulfhidrilo/sangre , Superóxido Dismutasa/sangre , Sustancias Reactivas al Ácido Tiobarbitúrico/análisis , Gemcitabina
10.
Mol Cell Biochem ; 371(1-2): 147-56, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22915168

RESUMEN

In this study, we investigated the effect of 6 weeks of swimming training on the ecto-nucleotidase activities and platelet aggregation from rats that developed hypertension in response to oral administration of L-NAME. The rats were divided into four groups: control (n = 10), exercise (n = 10), L-NAME (n = 10), and exercise L-NAME (n = 10). The animals were trained five times per week in an adapted swimming system for 60 min with a gradual increase of the workload up to 5 % of animal's body weight. The results showed an increase in ATP, ADP, AMP, and adenosine hydrolysis, indicating an augment in NTPDase (from 35.3 ± 8.1 to 53.0 ± 15.1 nmol Pi/min/mg protein for ATP; and from 21.7 ± 7.0 to 46.4 ± 15.6 nmol Pi/min/mg protein for ADP as substrate), ecto-5'-nucleotidase (from 8.0 ± 5.7 to 28.1 ± 6.9 nmol Pi/min/mg protein), and ADA (from 0.8 ± 0.5 to 3.9 ± 0.8 U/L) activities in platelets from L-NAME-treated rats when compared to other groups (p < 0.05). A significant augment on platelet aggregation in L-NAME group was also observed. Exercise training was efficient in preventing these alterations in the exercise L-NAME group, besides showing a significant hypotensive effect. In conclusion, our results clearly indicated a protector action of moderate intensity exercise on nucleotides and nucleoside hydrolysis and on platelet aggregation, which highlights the exercise training effect to avoid hypertension complications related to ecto-nucleotidase activities.


Asunto(s)
5'-Nucleotidasa/metabolismo , Plaquetas/metabolismo , Hipertensión/sangre , Condicionamiento Físico Animal , Adenosina Desaminasa/metabolismo , Adenosina Difosfato/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Hidrólisis , Masculino , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico/antagonistas & inhibidores , Óxido Nítrico/biosíntesis , Agregación Plaquetaria/efectos de los fármacos , Recuento de Plaquetas , Ratas , Ratas Wistar
11.
Biomed Pharmacother ; 66(3): 206-12, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22475627

RESUMEN

The aim of the present study was to investigate the effects in vivo and in vitro of nicotine, an important immunosuppressive agent, on NTPDase and ADA activities in lymphocytes of adult rats. The following nicotine doses in vivo study were evaluated: 0.0, 0.25 and 1.0mg/kg/day injected subcutaneously in rats for 10days. The activity of the enzymes were significantly decreased with nicotine 0.25 and 1mg/kg which inhibited ATP (22%, 54%), ADP (44%, 30%) hydrolysis and adenosine (43%, 34%) deamination, respectively. The expression of the protein NTPDase in rat lymphocytes was decreased to nicotine 1mg/kg and the lymphocytes count was decreased in both nicotine doses studied. The purine levels measured in serum of the rats treated with nicotine 0.25mg/kg significantly increased to ATP (39%), ADP (39%) and adenosine (303%). The nicotine exposure marker was determinate by level of cotinine level which significantly increased in rats treated with nicotine 0.25 (39%) and 1mg/kg (131%) when compared to rats that received only saline. The second set of study was in vitro assay which the ATP-ADP-adenosine hydrolysis were decreased by nicotine concentrations 1mM (0% - 0% - 16%, respectively), 5mM (42% - 32% - 74%, respectively), 10mM (80% - 27% - 80%, respectively) and 50mM (96% - 49% - 98%, respectively) when compared with the control group. We suggest that alterations in the activities of these enzymes may contribute to the understanding of the mechanisms involved in the suppression of immune response caused by nicotine.


Asunto(s)
Linfocitos/efectos de los fármacos , Linfocitos/enzimología , Nicotina/farmacología , Nucleotidasas/metabolismo , Adenosina/metabolismo , Adenosina Difosfato/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Cotinina/metabolismo , Hidrólisis/efectos de los fármacos , Linfocitos/metabolismo , Masculino , Purinas/metabolismo , Ratas , Ratas Wistar
12.
Biomed Pharmacother ; 66(1): 40-5, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22244962

RESUMEN

BACKGROUND: The nucleotides and nucleosides of adenine are signaling molecules related to thromboregulation and modulation of immune responses in patients with malignancies. Thus, this study aims to determine NTPDase, 5'-nucleotidase, ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP) and adenosine deaminase (ADA) activities in the platelets of patients with lung cancer. METHODS: We collected blood samples from patients (n=33) previously treated for lung cancer with chemotherapy. Patients were classified as stage IIIb and IV according to the Union for International Cancer Control (UICC). RESULTS: Patients showed a significant decrease in the hydrolysis of adenosine diphosphate (ADP) and adenosine, whereas the adenosine monophosphate (AMP) hydrolysis and platelet aggregation were significantly increased in this group. Adenosine triphosphate (ATP) hydrolysis did not show significant results between the group of patients and the control group. CONCLUSIONS: We may suggest that ectonucleotidases as well as ADA are enzymes involved in thromboembolic events but especially here we may see that they are also directly involved in the generation of adenosine formation in the cancer patient circulation.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/patología , Neoplasias Pulmonares/patología , Nucleósidos/metabolismo , Nucleótidos/metabolismo , Anciano , Anciano de 80 o más Años , Antineoplásicos/uso terapéutico , Plaquetas/metabolismo , Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Estudios de Casos y Controles , Femenino , Humanos , Hidrólisis , Neoplasias Pulmonares/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Agregación Plaquetaria
13.
Biomed Pharmacother ; 66(1): 6-11, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22257696

RESUMEN

INTRODUCTION: Cervical cancer remains the second leading cause of death among women. Intraepithelial neoplasias and uterine invasive cancer are frequently associated with disturbances in coagulation and changes in the concentrations of adenine nucleotides. This work intended to analyze changes in extracellular adenine nucleotide hydrolysis and blood platelet aggregation in patients diagnosed for cervical intraepithelial neoplasia in different stages as well as uterine invasive cancer. PATIENTS AND METHODS: NTPDase, E-NPP, 5'-nucleotidase, total ADA and its isoforms (ADA1 and ADA2), as well as the platelet aggregation from patients with different stages of cervical intraepithelial neoplasia (NICs I, NIC II, NIC III) and uterine invasive cancer were verified. RESULTS: Neither ATP hydrolysis nor E-NPP activity was changed by the neoplasia stage. On the other hand, ADP and AMP hydrolysis as well as ADA activity were enhanced in NIC I group. AMP hydrolysis was also increased in the cancer group. ADA 1 was the ADA isoform found in platelets from both control and patient groups. CONCLUSION: Our results showed for the first time that NTPDase, 5'-nucleotidase, E-NPP and ADA are not sensible regarding the grade of neoplasia development, since no significant difference was found between the groups studied. Only ADP hydrolysis and ADA activity showed a significant enhancement in NIC I group related to the other stages possibly as a result of the beginning of the neoplasic transformation. This increase could be reflecting a body's reaction against the probable high adenosine levels. We propose for the first time that the ADA isoform present in platelets is ADA 1.


Asunto(s)
Adenosina Desaminasa/metabolismo , Agregación Plaquetaria , Displasia del Cuello del Útero/patología , Neoplasias del Cuello Uterino/patología , Estudios de Casos y Controles , Femenino , Humanos , Hidrólisis , Isoenzimas , Invasividad Neoplásica , Estadificación de Neoplasias , Neoplasias del Cuello Uterino/enzimología , Displasia del Cuello del Útero/enzimología
14.
Cell Biochem Funct ; 29(8): 630-5, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22139626

RESUMEN

The aim of the present study was to investigate the effect of curcumin (Cur) on the activity of ectonucleoside triphosphate diphosphohydrolase (CD39), 5'-nucleotidase (CD73) and adenosine deaminase in platelets of cigarette smoke-exposed rats. For that purpose, we subjected male Wistar rats to a treatment with Cur and cigarette smoke, once a day, 5 days each week, for 30 days. The rats were treated by gavage with Cur or corn oil and then exposed to cigarette smoke. The experimental procedures were divided into two sets of experiments. In the first, the animals were divided into four groups: vehicle (corn oil) or Cur 12·5, 25 or 50 mg·kg(-1) . In the second, the animals were divided into five groups: vehicle (corn oil), smoke, or smoke and Cur 12·5, 25 or 50 mg·kg(-1) . The results showed that treatment with Cur significantly prevented the increased adenosine triphosphate (ATP) (121%) and adenosine monophosphate (AMP) (159%) and the decreased adenosine diphosphate (ADP) (51%) hydrolysis observed in the cigarette smoke-exposed rats Our results suggest that those purinergic enzyme alterations observed in the cigarette smoke-exposed rats could be related to an excessive platelet aggregation and point toward the potential of Cur to modulate purinergic signalling and, consequently, regulate the thrombus formation.


Asunto(s)
5'-Nucleotidasa/metabolismo , Nucleótidos de Adenina/metabolismo , Adenosina Desaminasa/metabolismo , Antígenos CD/metabolismo , Apirasa/metabolismo , Plaquetas/enzimología , Curcumina/farmacología , Extractos Vegetales/farmacología , Fumar/efectos adversos , 5'-Nucleotidasa/genética , Adenosina Desaminasa/genética , Animales , Antígenos CD/genética , Apirasa/genética , Plaquetas/metabolismo , Curcuma , Activación Enzimática/efectos de los fármacos , Humanos , Masculino , Agregación Plaquetaria/efectos de los fármacos , Ratas , Ratas Wistar , Nicotiana/efectos adversos
15.
Cell Biochem Funct ; 29(8): 703-7, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21932293

RESUMEN

With the evidence that curcumin may be a potent neuroprotective agent and that cigarette smoke is associated with a decline in the cognitive performance as our bases, we investigated the activities of Ecto-Nucleoside Triphosphate Diphosphohydrolase (NTPDase), 5'-nucleotidase and acetylcholinesterase (AChE) in cerebral cortex synaptosomes from cigarette smoke-exposed rats treated with curcumin (Cur). The experimental procedures entailed two sets of experiments. In the first set, the groups were vehicle, Cur 12·5, 25 and 50 mg·kg(-1) ; those in the second set were vehicle, smoke, smoke and Cur 12·5, 25 and 50 mg·kg(-1) . Curcumin prevented the increased NTPDase, 5'-nucleotidase and AChE activities caused by smoke exposure. We suggest that treatment with Cur was protective because the decrease of ATP and acetylcholine (ACh) concentrations is responsible for cognitive impairment, and both ATP and ACh have key roles in neurotransmission.


Asunto(s)
Acetilcolinesterasa/metabolismo , Adenosina Trifosfatasas/metabolismo , Corteza Cerebral/enzimología , Curcumina/administración & dosificación , Exposición a Riesgos Ambientales/efectos adversos , Nicotiana/efectos adversos , Humo/efectos adversos , Sinaptosomas/enzimología , Adenosina Trifosfatasas/antagonistas & inhibidores , Animales , Corteza Cerebral/efectos de los fármacos , Inhibidores Enzimáticos/administración & dosificación , Humanos , Masculino , Nucleotidasas/antagonistas & inhibidores , Nucleotidasas/metabolismo , Ratas , Ratas Wistar , Sinaptosomas/efectos de los fármacos , Contaminación por Humo de Tabaco/efectos adversos
16.
Diabetes Res Clin Pract ; 94(1): 84-90, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21737173

RESUMEN

The aim of the present study was to investigate the effects of Syzygium cumini leaf extract (ASc), on Adenosine deaminase (ADA) and Acetylcholinesterase (AChE) activities, and also on oxidative stress parameters in erythrocytes hemolysates (RBCs) and erythrocytes membranes (ghosts) from type 2 diabetics patients (Type 2 DM) under in vitro conditions. Non protein thiol groups (NP-SH), AChE, Catalase (CAT) and Superoxide Dismutase (SOD) activities were measure in RBCs. Further, ADA activity, Thiobarbituric Acid-Reactive Substances (TBARS) levels and protein thiol groups (P-SH) were estimated in ghosts. Also, P-SH and Vitamin C (VIT C) were measure in plasma sample. The results demonstrated that ADA and AChE activities, besides TBARS levels were higher in erythrocytes of Type 2 DM, while SOD activity and NP-SH levels were decreased when compared to control group. ASc, in vitro, reduced ADA and AChE activities and some parameters of oxidative stress. Furthermore, we observed correlations between VIT C and P-SH levels, ADA activity and P-SH levels, as well as NP-SH and TBARS levels in diabetics. The results suggest that ASc in vitro is able to promote the reduction of inflammation and oxidative stress parameters, and act against biochemical changes occurring in Diabetes mellitus (DM).


Asunto(s)
Antioxidantes/metabolismo , Diabetes Mellitus Tipo 2/enzimología , Diabetes Mellitus Tipo 2/metabolismo , Eritrocitos/enzimología , Eritrocitos/metabolismo , Extractos Vegetales/farmacología , Hojas de la Planta/química , Syzygium/química , Acetilcolinesterasa/metabolismo , Adenosina Desaminasa/metabolismo , Catalasa/metabolismo , Células Cultivadas , Eritrocitos/efectos de los fármacos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estrés Oxidativo/efectos de los fármacos , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo
17.
Basic Clin Pharmacol Toxicol ; 104(5): 408-13, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19413661

RESUMEN

Adenosine plays an important neuromodulatory role in the central nervous system, and adenosine deaminase is an important enzyme in the degradation of adenine nucleotides. Methylmercury is the most prevalent form of mercury found in the environment. Methylmercury neurotoxicity has been correlated to the production of reactive oxygen species. In this study, its potential pathogenic effects were investigated in vitro in cerebral cortex and hippocampus of rats. We first observed that adenosine deaminase activity was higher in young rat brains when compared to the 60-day-old rats and was higher in hippocampus when compared to the cortex. Methylmercury (0.1, 1.0, 20 microM) inhibited adenosine deaminase activity in 7- and 60-day-old rats in a concentration-dependent manner. We have demonstrated that methylmercury-induced inhibition was antagonized by garlic alcoholic extract, but sodium selenate did not alter enzyme activity. In addition, glutathione and dithiothreitol restored the methylmercury-induced decrease of adenosine deaminase activity. These results demonstrated that there are age-related changes in adenosine deaminase activity and that thiol agents may contribute to the maintenance of adenosine deaminase activity and may be important in the neuromodulation of adenosine. Garlic alcoholic extract may be effective in reducing the effect of methylmercury-induced adenosine deaminase, which may be due to its sulphur-containing compounds.


Asunto(s)
Adenosina Desaminasa/metabolismo , Envejecimiento/metabolismo , Corteza Cerebral/efectos de los fármacos , Ajo/química , Hipocampo/efectos de los fármacos , Metales Pesados/toxicidad , Compuestos de Metilmercurio/toxicidad , Extractos Vegetales/farmacología , Inhibidores de la Adenosina Desaminasa , Envejecimiento/efectos de los fármacos , Animales , Antioxidantes/farmacología , Corteza Cerebral/enzimología , Relación Dosis-Respuesta a Droga , Hipocampo/enzimología , Masculino , Extractos Vegetales/aislamiento & purificación , Ratas , Ratas Wistar , Ácido Selénico , Compuestos de Selenio/farmacología , Compuestos de Sulfhidrilo/metabolismo , Compuestos de Sulfhidrilo/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...